Revolution Medicines, Inc. · NASDAQ:RVMD

Clyburn Frank received 1,191 Revolution Medicines, Inc. shares as an award (Form 4)

Traded Jun 18, 2026 · Filed Jun 23, 2026

On Jun 18, 2026, Clyburn Frank (Director) received 1,191 Revolution Medicines, Inc. shares as an award, leaving 10,929 shares. Filed Jun 23, 2026 (Form 4).

Awarded
1,191 shares
Holding after
10,929 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 18, 2026Common StockAward1,19110,929Direct

Source

View original at SEC

Related